Latest filing published 07 Nov 2013 for HARVARD BIOSCIENCE INC.
Insider track record
No signal scores available.
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +2.6%Entry US$39.88 · Close at T+365 US$40.90
- +28.0%Entry US$28.20 · Close at T+365 US$36.09
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Chane Graziano: trading record in brief
Chane Graziano discloses dealings in 2 companies, chiefly Harvard Bioscience Inc and Harvard Apparatus Regenerative Technology, Inc. Over a trading history stretching from 4 June 2010 to 7 November 2013, the count stands at 28 filings.
Purchases make up the whole of the open-market record (9 purchases, €775k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 10 share grants and 7 option exercises. In 2013 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €59k. After 5 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +8.1%. These figures describe past trades and do not predict future prices.
The latest filing, published on 7 November 2013, reports a transaction in Harvard Bioscience Inc. The latest purchase dates back some time: it was published 4,820 days ago, on 29 August 2013. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Chane Graziano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares0Common StockSEC:0001181431-13-057596:0
- 100,000 shares0Common StockSEC:0001144204-13-059654:0
- 60,000 shares@ US$5.00Common StockSEC:0001181431-13-046864:0Canonical exit: 25 Nov 2013 (T+90)
- 400,000 shares@ US$3.18Common StockSEC:0001181431-13-042024:0
- 230,434 shares@ US$5.52Common StockSEC:0001181431-13-042024:1
- 300,000 shares@ US$1.99Common StockSEC:0001181431-13-042024:2
- 108,152 shares@ US$5.52Common StockSEC:0001181431-13-042024:3
- 125,000 shares@ US$4.01Common StockSEC:0001181431-13-042024:4
- 90,806 shares@ US$5.52Common StockSEC:0001181431-13-042024:5
- 300,000 shares@ US$4.28Common StockSEC:0001181431-13-042024:6
- 232,608 shares@ US$5.52Common StockSEC:0001181431-13-042024:7
- 125,000 shares@ US$2.98Common StockSEC:0001181431-13-042024:8
- 67,481 shares@ US$5.52Common StockSEC:0001181431-13-042024:9
- 50,289 shares@ US$3.57Common StockSEC:0001181431-13-042024:10
- 32,523 shares@ US$5.52Common StockSEC:0001181431-13-042024:11
- 200,000 shares@ US$3.48Common StockSEC:0001181431-12-064485:0
- 105,042 shares0Common StockSEC:0001181431-12-034338:0
- 53,750 shares0Common StockSEC:0001181431-11-035488:0
- 11,353 shares@ US$4.08Common StockSEC:0001181431-11-005417:0
- 6,200 shares@ US$3.45Common StockSEC:0001181431-10-046932:0Canonical exit: 12 Dec 2010 (T+90)
- 21,434 shares@ US$3.55Common StockSEC:0001181431-10-046932:1Canonical exit: 13 Dec 2010 (T+90)
- 62,361 shares@ US$3.60Common StockSEC:0001181431-10-046932:2Canonical exit: 14 Dec 2010 (T+90)
- 10,005 shares@ US$3.63Common StockSEC:0001181431-10-046932:3Canonical exit: 15 Dec 2010 (T+90)
- 133,600 shares0Common StockSEC:0001181431-10-031901:0
24 of 24 declarations
